Skip to content

US · AFYA · EDUCATION & TRAINING SERVICES

Afya Limited (AFYA) intrinsic value and stock valuation

$9.53as of 2026-11-21 · Mkt cap 1.25B

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Afya Limited DCF and intrinsic value

InvestorsCraft values AFYA with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from AFYA’s statements →

Afya Limited Graham Number

Graham Number: $99.56d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Consumer Defensive · Education & Training Services Belo Horizonte, MG 30130-917 institucional.afya.com.br

How the business is doing

Fiscal 2017–2025, USD

Revenue
$3.62B+24.7% 5y CAGRd
20172025
Net income
$737.7M+20.4% 5y CAGRd
20172025
Free cash flow
$1.04B+34.7% 5y CAGRd
20172025
Total equity
$4.89B+11.5% 5y CAGRd
20172025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2017–2025, USD
20252024202320222021
Revenue$3.62B$3.3B$2.88B$2.33B$1.72B
Operating income$1.19B$1.01B$767.1M$664.1M$440.9M
Net income$737.7M$631.5M$386.3M$373.6M$223.3M
EPSd$8.08M$6.93M$4.27M$4.15M$2.37M
Operating cash flow$1.2B$1.43B$1.04B$843.9M$630.9M
Capital expenditure-$-162.75M-$-392.62M-$-245.43M-$-297.02M-$-276.8M
Free cash flow$1.04B$1.04B$798.2M$546.9M$354.1M
Total assets$9.35B$8.83B$7.58B$7.2B$6.45B
Total debt$3.12B$3.17B$2.68B$2.71B$2.16B
Net debt$1.99B$2.26B$2.12B$1.62B$1.41B
Total equity$4.89B$4.31B$3.64B$3.25B$3B
Cash and short-term investments$1.12B$911M$553M$1.09B$748.6M
Income statement
20252024202320222021
Revenue$3.62B$3.3B$2.88B$2.33B$1.72B
Cost of revenue$1.29B$1.22B$1.11B$859.6M$652.3M
Gross profit$2.34B$2.09B$1.77B$1.47B$1.07B
Research and development expenses$0.00$20.1M$21.5M$9.44M$0.00
Selling, general and administrative expenses$1.15B$1.07B$1.01B$798.2M$622.6M
Other expenses$0.00-$-11M-$-37.15M$0.00$3.56M
Operating expenses$1.15B$1.08B$999M$805.6M$626.2M
Cost and expenses$2.44B$2.29B$2.11B$1.67B$1.28B
Interest income$0.00$43.4M$107.1M$27.2M$23M
Interest expense$493.8M$366.4M$386.3M$288.7M$175.7M
Depreciation and amortization$0.00$204.1M$289.5M$211.9M$154.2M
Ebitda$1.34B$1.22B$1.11B$929M$603.3M
Operating income$1.19B$1.01B$767.1M$664.1M$440.9M
Total other income/expenses, net-$-345.34M-$-335.72M-$-337.48M-$-235.67M-$-167.43M
Income before tax$844M$676.4M$429.6M$428.4M$273.5M
Income tax expense$90.7M$27.5M$24.2M$35.7M$31.2M
Net income$737.7M$631.5M$386.3M$373.6M$223.3M
Weighted average shares outstanding$90.5M$90.1M$90.5M$89.9M$93.3M
Weighted average diluted shares outstanding$91.3M$91.2M$90.5M$89.9M$94.1M
Balance sheet
20252024202320222021
Cash and short-term investments$1.12B$911M$553M$1.09B$748.6M
Net receivables$753.5M$621.6M$590.2M$480.6M$403.9M
Inventory$0.00$0.00$1.38M$12.2M$11.8M
Total current assets$1.94B$1.59B$1.2B$1.64B$1.21B
Property, plant and equipment, net$1.61B$1.5B$1.38B$1.23B$1.08B
Goodwill and intangible assets$5.59B$5.53B$4.8B$4.04B$3.9B
Long-term investments$81.5M$54.4M$51.8M$53.9M$48.5M
Total non-current assets$7.41B$7.24B$6.38B$5.56B$5.24B
Total assets$9.35B$8.83B$7.58B$7.2B$6.45B
Accounts payable$123.5M$313.4M$462.2M$333.2M$299M
Short-term debt$116.4M$409.1M$216.2M$239.8M$168.2M
Deferred revenue$158M$161.1M$153.5M$133.1M$114.6M
Total current liabilities$883.6M$1.14B$1.06B$905.7M$766.5M
Long-term debt$3B$2.76B$2.46B$2.47B$1.99B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$3.58B$3.38B$2.88B$3.04B$2.68B
Capital lease obligations$1.01B$978.3M$874.6M$769.5M$714.1M
Total liabilities$4.46B$4.52B$3.94B$3.95B$3.45B
Common stock$20K$20K$20K$20K$20K
Retained earnings$2.63B$2.01B$1.38B$1B$631.3M
Accumulated other comprehensive income (loss)$202.7M$187.5M$0.00$0.00$0.00
Total equity$4.89B$4.31B$3.64B$3.25B$3B
Total investments$81.5M$54.4M$51.8M$53.9M$48.5M
Total debt$3.12B$3.17B$2.68B$2.71B$2.16B
Net debt$1.99B$2.26B$2.12B$1.62B$1.41B
Cash flow statement
20252024202320222021
Net income$737.7M$676.4M$429.6M$428.4M$273.5M
Depreciation and amortization$0.00$333.3M$289.5M$206.2M$154.2M
Stock-based compensation$0.00$32.4M$31.5M$31.3M$43.4M
Change in working capital-$-208.81M-$-19.36M-$-59.39M-$-109.92M-$-48.8M
Accounts receivable-$-184.65M-$-79.34M-$-131.34M-$-129.16M-$-81.99M
Inventory$0.00$0.00$11M-$-360K-$-3.72M
Accounts payable-$-4.41M$18.1M$24.5M$9.97M$14.5M
Net cash provided by operating activities$1.2B$1.43B$1.04B$843.9M$630.9M
Investments in property, plant and equipment-$-356.86M-$-136.92M-$-118.44M-$-297.02M-$-125.87M
Acquisitions, net-$-141.25M-$-627.57M-$-907.52M-$-301.2M-$-1.01B
Net cash used for investing activities-$-498.11M-$-1.09B-$-1.14B-$-591.47M-$-1.27B
Common stock issued$25.2M$0.00$0.00$0.00$0.00
Common stock repurchased-$-75.49M$0.00-$-12.37M-$-152.32M-$-213.72M
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-489.2M$24M-$-439.94M$92.9M$364.7M
Net change in cash$317.2M$358M-$-540.05M$344.5M-$-296.48M
Cash at end of period$1.12B$911M$553M$1.09B$748.6M
Operating cash flow$1.2B$1.43B$1.04B$843.9M$630.9M
Capital expenditure-$-162.75M-$-392.62M-$-245.43M-$-297.02M-$-276.8M
Free cash flow$1.04B$1.04B$798.2M$546.9M$354.1M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Afya Limited

        Afya Limited, operating through its subsidiaries, is a prominent medical education provider in Brazil. The company delivers a comprehensive array of educational products and services primarily focused on the medical field, encompassing medical schools, preparatory courses for medical residency, advanced graduate studies, and various other programs tailored for medical professionals at all career stages. These offerings are available across its proprietary network and are also extended to external medical institutions. Beyond traditional education, Afya also offers digital health services through a subscription-based platform, accessible via a mobile app and website. This platform is specifically designed to assist healthcare practitioners and students with clinical decision-making by providing essential tools such as medical calculators, reference charts, up-to-date content, prescription guidance, clinical scoring systems, details on medical procedures, and laboratory examination information. While strong in medicine, Afya's educational portfolio spans a broader spectrum of health sciences, including dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine. Furthermore, the company extends its academic offerings beyond healthcare to include undergraduate and postgraduate degree programs in diverse subjects like business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. The company further enhances its educational ecosystem by providing specialized postgraduate medical programs, both printed and digital educational materials, an online medical learning platform, and hands-on medical training opportunities. As of December 31, 2021, Afya maintained an extensive network of 46 undergraduate and graduate medical school campuses, which included 30 operational undergraduate units and five approved units. This infrastructure supported a total capacity of 2,731 medical school seats, with 2,481 actively operating and an additional 278 seats approved for future use. Established in 1999, Afya Limited is headquartered in Nova Lima, Brazil.

        CEO
        Virgilio Deloy Capobianco Gibbon
        Employees
        9.4K
        Beta
        0.35

        Explore

        Frequently asked questions

        What is the intrinsic value of Afya Limited (AFYA)?

        Afya Limited (AFYA) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is AFYA undervalued?

        AFYA trades at a price of $9.53 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.